Evidence map›Paper›PMID 20041225›Full record

ArticlePLoS pathogens2009

Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Xiaofei Gao, Fengyi Wan, Kristina Mateo, Eduardo Callegari, Dan Wang, Wanyin Deng, Jose Puente, Feng Li, Michael S Chaussee, B Brett Finlay and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. EnteropathogeniceLife · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Cells · 2023
    Article
  7. Review
  8. Review
  9. Virulence · 2022
    Review
  10. Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenicProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Pathophysiology of enteropathogenicJournal of veterinary science · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. The T3SS Effector Protease NleC Is Active withinPathogens (Basel, Switzerland) · 2021
    Article
  19. Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Xiaofei GaoDepartment of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Fengyi Wan
Kristina Mateo
Eduardo Callegari
Dan Wang
Wanyin Deng
Jose Puente
Feng Li
Michael S Chaussee
B Brett Finlay
Michael J Lenardo
Philip R Hardwidge
South Dakota State University · USNational Institute of Allergy and Infectious Diseases · USUniversity of Kansas Medical Center · USUniversity of South Dakota · USCanada's Michael Smith Genome Sciences Centre · CAInstituto Nacional de Salud Pública · MXUniversity of British Columbia · CA

Funding

XRAY CRYSTALLOGRAPHY CORE (JANUARY 1 - JUNE 30, 2005)P20RR016443 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI VINES, CHARLOTTE M · 2001 to 2010
$21.3M
Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA BZIAAI000565 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LENARDO, MICHAEL J · 2009 to 2022
$5.2M
Emerging virulence factors in diarrheagenic E. coli pathogenesisR15AI070339 · NIAID · SOUTH DAKOTA STATE UNIVERSITY · PI HARDWIDGE, PHILIP ROSS · 2006 to 2006
$213k
Intramural NIH HHSNCRR NIH HHS P20 RR016443NIAID NIH HHS AI070339NIAID NIH HHS R15 AI070339
6 · The paper itself

Abstract

Enteric bacterial pathogens cause food borne disease, which constitutes an enormous economic and health burden. Enterohemorrhagic Escherichia coli (EHEC) causes a severe bloody diarrhea following transmission to humans through various means, including contaminated beef and vegetable products, water, or through contact with animals. EHEC also causes a potentially fatal kidney disease (hemolytic uremic syndrome) for which there is no effective treatment or prophylaxis. EHEC and other enteric pathogens (e.g., enteropathogenic E. coli (EPEC), Salmonella, Shigella, Yersinia) utilize a type III secretion system (T3SS) to inject virulence proteins (effectors) into host cells. While it is known that T3SS effectors subvert host cell function to promote diarrheal disease and bacterial transmission, in many cases, the mechanisms by which these effectors bind to host proteins and disrupt the normal function of intestinal epithelial cells have not been completely characterized. In this study, we present evidence that the E. coli O157:H7 nleH1 and nleH2 genes encode T3SS effectors that bind to the human ribosomal protein S3 (RPS3), a subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) transcriptional complexes. NleH1 and NleH2 co-localized with RPS3 in the cytoplasm, but not in cell nuclei. The N-terminal region of both NleH1 and NleH2 was required for binding to the N-terminus of RPS3. NleH1 and NleH2 are autophosphorylated Ser/Thr protein kinases, but their binding to RPS3 is independent of kinase activity. NleH1, but not NleH2, reduced the nuclear abundance of RPS3 without altering the p50 or p65 NF-kappaB subunits or affecting the phosphorylation state or abundance of the inhibitory NF-kappaB chaperone IkappaBalpha NleH1 repressed the transcription of a RPS3/NF-kappaB-dependent reporter plasmid, but did not inhibit the transcription of RPS3-independent reporters. In contrast, NleH2 stimulated RPS3-dependent transcription, as well as an AP-1-dependent reporter. We identified a region of NleH1 (N40-K45) that is at least partially responsible for the inhibitory activity of NleH1 toward RPS3. Deleting nleH1 from E. coli O157:H7 produced a hypervirulent phenotype in a gnotobiotic piglet model of Shiga toxin-producing E. coli infection. We suggest that NleH may disrupt host innate immune responses by binding to a cofactor of host transcriptional complexes.

Indexed as

Amino Acid SequenceAnimalsChromatography, LiquidEnterohemorrhagic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsFluorescent Antibody TechniqueHost-Parasite InteractionsHumansImmunoblottingImmunoprecipitationMass SpectrometryMolecular Sequence DataNF-kappa BReverse Transcriptase Polymerase Chain ReactionRibosomal ProteinsEscherichia coli ProteinsNF-kappa BNleI protein, E coliRibosomal ProteinsRPS3A protein, human

Identifiers

PMID20041225
PMCPMC2791202
OpenAlexW2029066749

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.